Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company headquartered ...
Rhinocare Korea, a medtech innovator specialising in drug-free respiratory care, has announced plans to establish a join...
What were the key highlights at Sygnature Discovery in 2025? Please elaborate upon the company's plans for 2026. Despit...
China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutica...
Pillar Biosciences and AstraZeneca have announced an expansion of their existing laboratory access programme for NG...
Australia-based Immutep Limited and Dr. Reddy’s Laboratories, based in India, have announced that their ...
Leading European biopharmaceutical company, Menarini Asia-Pacific, has announced the expansion of its export manufacturi...
Australia’s onshore vaccine manufacturing capabilities took a leap forward as Mark Butler MP, Minister for Health,...
South Korea-based Samsung Bioepis Co. has announced the launch of OBODENCE™ (60 mg pre-filled syringe) a...
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced the grand opening of its new state-of-the-...
Japan's Fujitsu Limited has announced the development of a multi-AI agent collaboration technology that enable...
SAI Parenterals Limited (SPL), an India-based pharmaceutical formulation company, has announced the acquisition of a 74....
Singapore-based startup Patronus Biotech has announced a grant from the Gates Foundation to accelerate the development o...
According to reports, the APAC MedTech market is valued at $16.3 billion in 2025, with a potential to reach $18.6 billio...
2025 was the year when China’s stratospheric rise on the global biotech stage continued. According to a report fro...
SK Biopharmaceuticals, a South Korea-based biotech company specialising in research, development, and commercialisation ...
The US Food and Drug Administration (FDA) has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spin...
Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, has signed an exclusive licensing agreement wi...
